Takeda’s Soticlestat Fails In Seizure Trials

 
• By Jessica Merrill
  
Missed target
Two of Takeda's Phase III studies missed the primary endpoint • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D